Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Argye Elizabeth Hillis MD, MA Associate Editor

Marinos C. Dalakas MD, FAAN Advisory Board

Mark Hallett MD Editor-in-Chief

See All Experts

Published in Neurology and

Journal Scan / Research · May 23, 2024

Artificial Intelligence–Based Thalamic Volumetrics and Cognition in Patients With MS

NeuroImage: Clinical

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Ahmed Obeidat MD, PhD

NeuroImage: Clinical

Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis

Neuroimage Clin 2024 Apr 27;42(xx)103609, R Zivadinov, N Bergsland, D Jakimovski, B Weinstock-Guttman, L Lorefice, MM Schoonheim, SA Morrow, M Ann Picone, G Pardo, M Zarif, M Gudesblatt, JA Nicholas, A Smith, S Hunter, S Newman, MA AbdelRazek, I Hoti, J Riolo, D Silva, TA Fuchs, MG Dwyer, R Hb Benedict

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Multiple Sclerosis

Artificial Intelligence–Based Thalamic Volumetrics and Cognition in Patients With MS

Additional Info

Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis

Further Reading

Appointment Non-Attendance Is Associated With Disease-Modifying Therapy Persistence the Following Year

Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma

Transcranial Direct Current Stimulation Improves Tardive Dyskinesia in Long-Term Hospitalized Patients With Chronic Schizophrenia

Circular RNA in Patients With Parkinson's Disease: From Involvement in Pathology to Diagnostic Tools in At-Risk Individuals

Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma

Neurologic Outcomes in People With MS Treated With Immune Checkpoint Inhibitors for Oncologic Indications

FDA Approves Kebilidi for Aromatic L-Amino Acid Decarboxylase Deficiency

Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma

Association Between Health-Related Behaviors and the Risk of Common Age-Related Brain Diseases Across Severities of Genetic Risk

High-Dose Folic Acid Use and Cancer Risk in Women Who Have Given Birth

Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Patients With Acute Ischemic Stroke

Recently Updated